Perillyl alcohol: applications in oncology

Area of Science:

• Natural Products Chemistry
• Oncology
• Pharmacology

Background:

• Perillyl alcohol is a naturally occurring monoterpene found in various plant essential oils.
• It has demonstrated anti-cancer properties in preclinical animal studies, including tumor regression and chemopreventive potential.
• Its mechanisms involve inducing apoptosis and promoting differentiation in cancer cells while sparing normal cells.

Purpose of the Study:

• To summarize the potential applications and observed effects of perillyl alcohol in cancer research.
• To review the proposed mechanisms of action for perillyl alcohol's anti-cancer activity.
• To present findings from preliminary human trials regarding efficacy and side effects.

Main Methods:

• Review of animal studies investigating perillyl alcohol's effects on various tumor types.
• Analysis of in vitro studies examining cellular mechanisms of action.
• Evaluation of preliminary human clinical trial data.

Main Results:

• Perillyl alcohol demonstrated tumor regression in animal models of pancreatic, mammary, liver, colon, skin, lung, neuroblastoma, and prostate cancers.
• It selectively induces apoptosis in tumor cells and promotes cellular differentiation.
• Mechanisms include modulation of growth factor receptors, Bak expression, ras protein prenylation, ubiquinone synthesis, and detoxification systems.
• Preliminary human trials showed no tumor regression at the specified dosage and reported significant gastrointestinal side effects.

Conclusions:

• Perillyl alcohol exhibits significant anti-cancer potential in preclinical models through apoptosis induction and differentiation.
• Further research is needed to clarify its therapeutic window and optimize treatment strategies for human application.
• The observed side effects in human trials necessitate careful consideration for clinical use.